Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Arox W, Kamng'ona"'
Autor:
Chrispin Chaguza, Innocent Chibwe, David Chaima, Patrick Musicha, Latif Ndeketa, Watipaso Kasambara, Chimwemwe Mhango, Upendo L. Mseka, Joseph Bitilinyu-Bangoh, Bernard Mvula, Wakisa Kipandula, Patrick Bonongwe, Richard J. Munthali, Selemani Ngwira, Chikondi A. Mwendera, Akuzike Kalizang’oma, Kondwani C. Jambo, Dzinkambani Kambalame, Arox W. Kamng’ona, A. Duncan Steele, Annie Chauma-Mwale, Daniel Hungerford, Matthew Kagoli, Martin M. Nyaga, Queen Dube, Neil French, Chisomo L. Msefula, Nigel A. Cunliffe, Khuzwayo C. Jere
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-15 (2024)
Abstract Malawi experienced its deadliest Vibrio cholerae (Vc) outbreak following devastating cyclones, with >58,000 cases and >1700 deaths reported between March 2022 and May 2023. Here, we use population genomics to investigate the attributes and o
Externí odkaz:
https://doaj.org/article/6b7cbc3890c14711a1a922c4cd6b9c0a
Autor:
Arox W, Kamng’ona *, Rebecca, Young, Charles D, Arnold, Noel, Patson, Josh M, Jorgensen, Emma, Kortekangas, David, Chaima, Chikondi, Malamba, Ulla, Ashorn, Yin B, Cheung, Per, Ashorn, Kenneth, Maleta, Kathryn G, Dewey
Publikováno v:
In The Journal of Nutrition April 2020 150(4):918-928
Autor:
Todd D. Swarthout, Claudio Fronterre, José Lourenço, Uri Obolski, Andrea Gori, Naor Bar-Zeev, Dean Everett, Arox W. Kamng’ona, Thandie S. Mwalukomo, Andrew A. Mataya, Charles Mwansambo, Marjory Banda, Sunetra Gupta, Peter Diggle, Neil French, Robert S. Heyderman
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-12 (2020)
Impact of pneumococcal conjugate vaccines (PCV) in controlling carriage needs to be evaluated to inform vaccine policy. Here, Swarthout et al. show in a prospective rolling cross-sectional study in Malawi a high residual prevalence of vaccine-serotyp
Externí odkaz:
https://doaj.org/article/ae7ea6f71d874cce94b21be785b45e8c
Autor:
Prisca Benedicto-Matambo, Julie E. Bines, Chikondi Malamba-Banda, Isaac T. Shawa, Kayla Barnes, Arox W. Kamng’ona, Daniel Hungerford, Kondwani C. Jambo, Miren Iturriza-Gomara, Nigel A. Cunliffe, Katie L. Flanagan, Khuzwayo C. Jere
Publikováno v:
Vaccines, Vol 10, Iss 3, p 418 (2022)
Following the introduction of live-attenuated rotavirus vaccines in many countries, a notable reduction in deaths and hospitalisations associated with diarrhoea in children
Externí odkaz:
https://doaj.org/article/87c6004a9a3a462990207b720a0d64de
Autor:
Jonathan J. Mandolo, Marc Y. R. Henrion, Chimwemwe Mhango, End Chinyama, Richard Wachepa, Oscar Kanjerwa, Chikondi Malamba-Banda, Isaac T. Shawa, Daniel Hungerford, Arox W. Kamng’ona, Miren Iturriza-Gomara, Nigel A. Cunliffe, Khuzwayo C. Jere
Publikováno v:
Viruses, Vol 13, Iss 12, p 2491 (2021)
Rotavirus is the major cause of severe gastroenteritis in children aged ® rotavirus vaccine in Malawi in 2012 has reduced rotavirus-associated hospitalisations and diarrhoeal mortality. However, the impact of rotavirus vaccine on the severity of gas
Externí odkaz:
https://doaj.org/article/07bdbcb1592742e5af6f2a343bd96279
Autor:
Chimwemwe Mhango, Akuzike Banda, End Chinyama, Jonathan J Mandolo, Orpha Kumwenda, Chikondi Malamba-Banda, Kayla G Barnes, Benjamin Kumwenda, Kondwani Jambo, Celeste M Donato, Mathew D Esona, Peter N Mwangi, A Duncan Steele, Miren Iturriza-Gomara, Nigel A Cunliffe, Valentine N Ndze, Arox W Kamng’ona, Francis E Dennis, Martin M Nyaga, Chrispin Chaguza, Khuzwayo C Jere
Publikováno v:
Virus Evolution.
G3 rotaviruses rank among the most common rotavirus strains worldwide in humans and animals. However, despite a robust long-term rotavirus surveillance system from 1997 at Queen Elizabeth Central Hospital in Blantyre, Malawi, these strains were only
Autor:
Jonathan Mandolo, Edward P. K. Parker, Christina Bronowski, Kulandaipalayam Natarajan C. Sindhu, Alistair C. Darby, Nigel A. Cunliffe, Gagandeep Kang, Miren Iturriza-Gómara, Arox W. Kamng’ona, Khuzwayo C. Jere
BackgroundMaternal breastmilk is a source of pre- and pro-biotics that impact neonatal gut microbiota colonisation. Since oral rotavirus vaccines (ORVs) are administered at a time when infants are often breastfed, breastmilk microbiota composition ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::93f78b5fbf3c1aa744ffdd9613c9a862
https://doi.org/10.1101/2022.11.09.22282115
https://doi.org/10.1101/2022.11.09.22282115
Autor:
Chimwemwe Mhango, Akuzike Banda, End Chinyama, Jonathan J. Mandolo, Orpha Kumwenda, Chikondi Malamba-Banda, Kayla G. Barnes, Benjamin Kumwenda, Kondwani Jambo, Celeste M. Donato, Mathew D. Esona, Peter N. Mwangi, A. Duncan Steele, Miren Iturriza-Gomara, Nigel A. Cunliffe, Valentine N. Ndze, Arox W. Kamng’ona, Francis E. Dennis, Martin M. Nyaga, Chrispin Chaguza, Khuzwayo C. Jere
Genotype G3 rotaviruses rank among the most common rotavirus strains worldwide in humans and animals. However, despite a robust long-term rotavirus surveillance system from 1997 in Blantyre, Malawi, these strains were only detected from 1997 to 1999
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::880e518a33763cfced661b70af9ac334
https://doi.org/10.1101/2022.10.04.22280678
https://doi.org/10.1101/2022.10.04.22280678
Autor:
Kondwani C. Jambo, Dumizulu L. Tembo, Arox W. Kamng'ona, Patrick Musicha, Dominic H. Banda, Anstead M. Kankwatira, Rose D. Malamba, Theresa J. Allain, Robert S. Heyderman, David G. Russell, Henry C. Mwandumba
Publikováno v:
ERJ Open Research, Vol 3, Iss 4 (2017)
Externí odkaz:
https://doaj.org/article/18f792675edd4729ae9e70c02ede4f93
Autor:
Peter N. Mwangi, Nicola A. Page, Mapaseka L. Seheri, M. Jeffrey Mphahlele, Sandrama Nadan, Mathew D. Esona, Benjamin Kumwenda, Arox W. Kamng’ona, Celeste M. Donato, Duncan A. Steele, Valantine N. Ndze, Francis E. Dennis, Khuzwayo C. Jere, Martin M. Nyaga
Publikováno v:
Microbial genomics. 8(4)
The transient upsurge of G2P[4] group A rotavirus (RVA) after Rotarix vaccine introduction in several countries has been a matter of concern. To gain insight into the diversity and evolution of G2P[4] strains in South Africa pre- and post-RVA vaccina